Suchergebnisse - "Liedert, Bernd"

PubPharm (7)

1

A phase I dose-escalation study of the immunocytokine EMD 521873 (Selectikine) in patients with advanced solid tumours

enthalten in: European journal of cancer (Oxford, England : 1990) | 2013

von Gillessen, S. | Gnad-Vogt, U. | Gallerani, E. | +9

2

T-cell activation by treatment of cancer patients with EMD 521873 (Selectikine), an IL-2/anti-DNA fusion protein

enthalten in: Journal of translational medicine | 2013

von Laurent, J. | Touvrey, C. | Gillessen, S. | +13

3

Erythropoietin overrides the triggering effect of DNA platination products in a mouse model of cisplatin-induced neuropathy

enthalten in: BMC neuroscience | 2009

von Yoon, M. | Katsarava, Z. | Obermann, M. | +8

4

High accumulation of platinum-DNA adducts in strial marginal cells of the cochlea is an early event in cisplatin but not carboplatin ototoxicity

enthalten in: Molecular pharmacology | 2006

von Thomas, J. | Lautermann, J. | Liedert, B. | +2

5

Adduct-specific monoclonal antibodies for the measurement of cisplatin-induced DNA lesions in individual cell nuclei

enthalten in: Nucleic acids research | 2006

von Liedert, B. | Pluim, D. | Schellens, J. | +1

6

Protection of platinum-DNA adduct formation and reversal of cisplatin resistance by anti-MRP2 hammerhead ribozymes in human cancer cells

enthalten in: International journal of cancer | 2005

von Materna, V. | Liedert, B. | Thomale, J. | +1

7

Overexpression of cMOAT (MRP2/ABCC2) is associated with decreased formation of platinum-DNA adducts and decreased G2-arrest in melanoma cells resistant to cisplatin

enthalten in: The Journal of investigative dermatology | 2003

von Liedert, B. | Materna, V. | Schadendorf, D. | +2

1
[1]